BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 37974075)

  • 1. Necrosis-Inducing High-Valent Oxo-Rhenium(V) Complexes with Potent Antitumor Activity: Synthesis, Aquation Chemistry, Cisplatin Cross-Resistance Profile, and Mechanism of Action.
    Das S; Joshi P; Patra M
    Inorg Chem; 2023 Dec; 62(48):19720-19733. PubMed ID: 37974075
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In Vitro Anticancer Activity and in Vivo Biodistribution of Rhenium(I) Tricarbonyl Aqua Complexes.
    Knopf KM; Murphy BL; MacMillan SN; Baskin JM; Barr MP; Boros E; Wilson JJ
    J Am Chem Soc; 2017 Oct; 139(40):14302-14314. PubMed ID: 28948792
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emissive behavior, cytotoxic activity, cellular uptake, and PEGylation properties of new luminescent rhenium(I) polypyridine poly(ethylene glycol) complexes.
    Choi AW; Louie MW; Li SP; Liu HW; Chan BT; Lam TC; Lin AC; Cheng SH; Lo KK
    Inorg Chem; 2012 Dec; 51(24):13289-302. PubMed ID: 23198846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combinatorial Synthesis to Identify a Potent, Necrosis-Inducing Rhenium Anticancer Agent.
    Konkankit CC; Vaughn BA; MacMillan SN; Boros E; Wilson JJ
    Inorg Chem; 2019 Mar; 58(6):3895-3909. PubMed ID: 30793900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The in vitro renal cell toxicity of some unconventional anticancer phenanthroline-based platinum(II) complexes.
    Ng NS; Wu MJ; Myers SJ; Aldrich-Wright JR
    J Inorg Biochem; 2018 Feb; 179():97-106. PubMed ID: 29197671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platinum(II) complexes of imidazophenanthroline-based polypyridine ligands as potential anticancer agents: synthesis, characterization, in vitro cytotoxicity studies and a comparative ab initio, and DFT studies with cisplatin, carboplatin, and oxaliplatin.
    Alexander C; Nithyakumar A; Paul MWB; Arockia Samy N
    J Biol Inorg Chem; 2018 Jul; 23(5):833-848. PubMed ID: 29934700
    [TBL] [Abstract][Full Text] [Related]  

  • 7. East-west fusion-necrosis and apoptosis acting in concert by demethylcantharidin-integrated platinum complexes.
    Pang SK; So WK; Ho YP; Au-Yeung CF
    Anticancer Agents Med Chem; 2014 Jun; 14(5):756-61. PubMed ID: 24476313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. May iron(III) complexes containing phenanthroline derivatives as ligands be prospective anticancer agents?
    Matos CP; Adiguzel Z; Yildizhan Y; Cevatemre B; Onder TB; Cevik O; Nunes P; Ferreira LP; Carvalho MD; Campos DL; Pavan FR; Pessoa JC; Garcia MH; Tomaz AI; Correia I; Acilan C
    Eur J Med Chem; 2019 Aug; 176():492-512. PubMed ID: 31132480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploring the cytotoxic activity of new phenanthroline salicylaldimine Zn(II) complexes.
    Matos CP; Addis Y; Nunes P; Barroso S; Alho I; Martins M; Matos APA; Marques F; Cavaco I; Costa Pessoa J; Correia I
    J Inorg Biochem; 2019 Sep; 198():110727. PubMed ID: 31195153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Square planar Au(III), Pt(II) and Cu(II) complexes with quinoline-substituted 2,2':6',2″-terpyridine ligands: From in vitro to in vivo biological properties.
    Choroba K; Machura B; Szlapa-Kula A; Malecki JG; Raposo L; Roma-Rodrigues C; Cordeiro S; Baptista PV; Fernandes AR
    Eur J Med Chem; 2021 Jun; 218():113404. PubMed ID: 33823390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Necroptosis-inducing rhenium(V) oxo complexes.
    Suntharalingam K; Awuah SG; Bruno PM; Johnstone TC; Wang F; Lin W; Zheng YR; Page JE; Hemann MT; Lippard SJ
    J Am Chem Soc; 2015 Mar; 137(8):2967-74. PubMed ID: 25698398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rhenium(I) Tricarbonyl Complexes of 1,10-Phenanthroline Derivatives with Unexpectedly High Cytotoxicity.
    Enslin LE; Purkait K; Pozza MD; Saubamea B; Mesdom P; Visser HG; Gasser G; Schutte-Smith M
    Inorg Chem; 2023 Aug; 62(31):12237-12251. PubMed ID: 37489813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potent Ruthenium-Ferrocene Bimetallic Antitumor Antiangiogenic Agent That Circumvents Platinum Resistance: From Synthesis and Mechanistic Studies to
    M M; Gadre S; Chhatar S; Chakraborty G; Ahmed N; Patra C; Patra M
    J Med Chem; 2022 Dec; 65(24):16353-16371. PubMed ID: 36459415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic potential of vanadium complexes with 1,10-phenanthroline ligands, quo vadis? Fate of complexes in cell media and cancer cells.
    Nunes P; Correia I; Cavaco I; Marques F; Pinheiro T; Avecilla F; Pessoa JC
    J Inorg Biochem; 2021 Apr; 217():111350. PubMed ID: 33477088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel star-shaped trinuclear platinum(II) complex based on a 1,3,5-triazine core displaying potent antiproliferative activity against TNBC by the mitochondrial injury and DNA damage mechanism.
    Wu Y; Zhao D; Shang J; Huang W; Chen Z
    Dalton Trans; 2022 Jul; 51(29):10930-10942. PubMed ID: 35731536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disruption of the Microtubule Network and Inhibition of VEGFR2 Phosphorylation by Cytotoxic
    Acharya S; Maji M; Chakraborty MP; Bhattacharya I; Das R; Gupta A; Mukherjee A
    Inorg Chem; 2021 Mar; 60(5):3418-3430. PubMed ID: 33554592
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platinum(II) Complexes with 1,10-Phenanthroline and Hydrophilic Alkoxyacetate Ligands as Potential Antitumor Agents.
    Sun Y; Wei H; Zhang Q; Zhao X
    Chem Biodivers; 2019 Jan; 16(1):e1800373. PubMed ID: 30414350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systematic evaluation of the antitumor activity of three ruthenium polypyridyl complexes.
    Jiang GB; Zhang WY; He M; Gu YY; Bai L; Wang YJ; Yi QY; Du F
    J Inorg Biochem; 2021 Dec; 225():111616. PubMed ID: 34555601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis of Pt(II) complexes of the type [Pt(1,10-phenanthroline)(SArF
    Backman-Blanco G; Valdés H; Ramírez-Apan MT; Cano-Sanchez P; Hernandez-Ortega S; Orjuela AL; Alí-Torres J; Flores-Gaspar A; Reyes-Martínez R; Morales-Morales D
    J Inorg Biochem; 2020 Oct; 211():111206. PubMed ID: 32801098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Organometallic Iridium(III) anticancer complexes with new mechanisms of action: NCI-60 screening, mitochondrial targeting, and apoptosis.
    Hearn JM; Romero-Canelón I; Qamar B; Liu Z; Hands-Portman I; Sadler PJ
    ACS Chem Biol; 2013; 8(6):1335-43. PubMed ID: 23618382
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.